FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/095395 [Registered on: 24/09/2025] Trial Registered Prospectively
Last Modified On: 24/09/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Ocular irritation study]  
Study Design  Other 
Public Title of Study   A study to evaluate ocular irritation of test product on human subjects 
Scientific Title of Study   Evaluation of the Perceived Discomfort and/or Eye Irritation Potential of Test Product in Adult Human Subjects 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NB250042-US, version_1.0, 20Apr25  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nayan Patel 
Designation  Principal Investigator - Medical Director 
Affiliation  NovoBliss Research Private Limited 
Address  NovoBliss Research Pvt. Ltd. office 313, Silver Radiance-4, Gota, Ahmedabad, Gujarat,India - Ahmedabad, Gujarat, India - 382481. Ahmadabad GUJARAT 382481 India

Ahmadabad
GUJARAT
382481
India 
Phone  07948983895  
Fax    
Email  dr.nayan@novobliss.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nayan Patel 
Designation  Principal Investigator - Medical Director 
Affiliation  NovoBliss Research Private Limited 
Address  NovoBliss Research Pvt. Ltd. office 313, Silver Radiance-4, Gota, Ahmedabad, Gujarat,India - Ahmedabad, Gujarat, India - 382481. Ahmadabad GUJARAT 382481 India

Ahmadabad
GUJARAT
382481
India 
Phone  07948983895  
Fax    
Email  dr.nayan@novobliss.in  
 
Details of Contact Person
Public Query
 
Name  Maheshvari Patel 
Designation  Director Operations and Strategic Management 
Affiliation  NovoBliss Research Private Limited 
Address  NovoBliss Research Pvt. Ltd. office 313, Silver Radiance-4, Gota, Ahmedabad, Gujarat,India Ahmedabad, Gujarat, India - 382481. Ahmadabad GUJARAT 382481 India

Ahmadabad
GUJARAT
382481
India 
Phone  9909013236  
Fax    
Email  maheshvari@novobliss.in  
 
Source of Monetary or Material Support  
Uprising Science Pvt. Ltd 
 
Primary Sponsor  
Name  Uprising Science Pvt. Ltd 
Address  2nd Floor, Khasra No. 55, Commercial Building, Hotel Marriott, Ramdas Agrawal Marg, Near Jawahar Circle Jaipur Jaipur-302015, Rajasthan  
Type of Sponsor  Other [Hair and skin care manufacturer] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nayan Patel  NovoBliss Research Private Limited  313, SilverRadiance-4, Gota, Ahmedabad, Gujarat,India - 382481. Ahmadabad GUJARAT382481 India Ahmadabad GUJARAT
Ahmadabad
GUJARAT 
07948983895

dr.nayan@novobliss.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ACEAS Independent Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  The study Participant is in general good health and has both eyes 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Control  Tap Water 
Intervention  Minimalist Marula Oil 05% Cleansing Oil  Mode of Usage: Take required quantity of product on fingertips and massage gently on face to remove make-up and dirt Frequency: Once a Day Route of administration: Topical Study duration : 15 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  1.Participant is in general good health and has both eyes.
2.Understand the test procedures and agree to adhere to study requirements, instructions and procedures.
3.Males and Females (non-pregnant/non-lactating).
4.Ages 18-45 years both inclusive.
5.Females who wears eye makeup.
6.The study general eye evaluation as assessed by trained clinicians.
7.Pass an eye sting evaluation using isotonic saline.
8.Study participants are willing to refrain from using any eye drops on the day of the study.
 
 
ExclusionCriteria 
Details  1.Currently or within the last 2 weeks using eye drops (such as saline solutions, Netra-Prabha, Drasty, etc).
2.Have worn contact lenses during the study period. (12 months).
3.Have any of the following conditions or factors that may affect the interpretation of the test results, including but not limited to, diabetes (controlled or uncontrolled), currently pregnant, or currently lactating or have lactated within the last 4 months.
4.Have participated in a study with the eyes as the target area within 6 weeks of the start of the study.
5.Be participating in any other study concurrently.
6.Be involved in any aspect of study administration, i.e., evaluating applying products, etc.
7.Have a history of sensitivity and/or adverse reactions to preparations intended for the eyes.
8.Ever had any eye conditions such as glaucoma, cataracts, exophthalmos (protuberance of the eye), etc.
9.Subject currently having any eye infections or irritation.
10.The subject is having any sensitivity to eye make-up.
11.Currently have any eye infections or irritation including blepharitis, general lid inflammation, conjunctivitis, or an eye discharge within two weeks of the study.
12.Ever had any eye surgery (including Lasik, laser eye surgery).
13.Currently using any topical medications on the face or any medications intended for the eyes.
14.Consume any alcoholic beverages during the days of the study.
15.Have taken antihistamines (including those in cold tablets, OTC allergy medications, decongestants and inhalants) or analgesics (including aspirin or other over-the-couter analgesics) on the days of the study.
16.Have any other condition or factor that the Investigator or Ophthalmologist believes may affect the stinging or tearing response or the interpretation of the results.
17.Currently taking any prescription pain medications.
18.Have smoked within 1 hour before each study visit or during the study visit
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.To assess the irritation and stinging/discomfort effect of the test product as comparedto control with both subjective sting/irritation and objective evaluations.
2.To assess the visual effect i.e., degree of inflammation of bulbar conjunctiva, palpebralconjunctiva, and lacrimation of test product as compared with the control.
3.To evaluate the effectiveness of the test product in subject perception questionnaire 
Day 01, 07 and 15 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="10"
Sample Size from India="10" 
Final Enrollment numbers achieved (Total)= "10"
Final Enrollment numbers achieved (India)="10" 
Phase of Trial   N/A 
Date of First Enrollment (India)   18/10/2025 
Date of Study Completion (India) 14/10/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="0"
Days="15" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The subject will take a test product on their fingertip and then gently massage of the test product onto the eye area (with the eye closed) for 30 seconds to simulate the removal of the eye-make up, dirt, sweat etc. The subject will then be asked to open their eyes and to rate the intensity of perceived discomfort/irritation using the Stinging/Discomfort Scale. This score will be recorded on the Test product Evaluation form. The subject will then be asked to rinse the eye with 6 handfuls of water (which takes about 10 seconds), re-open the eye, and rate the intensity of discomfort/stinging after rinsing. The subject will be instructed to continue rinsing the eye using the same procedure (6 handfuls of water) until the stinging score reaches 0. The water should be running the entire time during this procedure for emergency situations. If more than one sink is used, ensure that the water pressure is consistent in all sinks. After rinsing each eye, the subjects may gently pat dry each eye, but may not rub the eye to avoid any irritation. Any remaining eyeliner can be removed after the subject sees the ophthalmologist for the final evaluation. Once the washing procedure has been completed, the subject will return to the ophthalmologist-trained evaluator | optometrist within 5 minutes after completing the wash procedure

 
Close